JNHMF logo

Jack Nathan Medical Corp. (JNHMF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

JNHMF representa a Jack Nathan Medical Corp., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 45/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 45/100

Jack Nathan Medical Corp. (JNHMF) Resumen de Asistencia Médica y Tuberías

CEOMichael Di Cesare
Sede CentralWoodbridge, CA
Año de la oferta pública inicial (OPI)2020

Jack Nathan Medical Corp. operates primary care clinics within Walmart Supercentres, providing accessible healthcare services in Canada and Mexico. With a high gross margin of 87.4% and a presence in numerous Walmart locations, the company focuses on convenient, integrated healthcare solutions, distinguishing itself through its retail-based clinic model.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Jack Nathan Medical Corp. presents a unique investment opportunity within the healthcare sector, driven by its strategic partnership with Walmart and its focus on convenient, accessible primary care. With a high gross margin of 87.4% and a profit margin of 271.5%, the company demonstrates strong profitability. Growth catalysts include further expansion within Walmart locations in Canada and Mexico, as well as potential partnerships with other retail chains. Key value drivers include increasing patient volume, expanding service offerings, and leveraging the company's brand recognition. However, investors should be aware of potential risks, including competition from other healthcare providers, regulatory changes, and the company's reliance on its relationship with Walmart. The company's beta of -0.24 suggests a low correlation with the overall market, potentially offering downside protection during market downturns.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Operates 76 clinics in Walmart locations in Canada as of June 30, 2022, providing convenient healthcare access.
  • Maintains a high gross margin of 87.4%, indicating efficient cost management and strong pricing power.
  • Achieved a profit margin of 271.5%, showcasing exceptional profitability.
  • Operates 108 corporate-owned and operated clinics in Walmart locations in Mexico, demonstrating international expansion.
  • Beta of -0.24 suggests low correlation with the overall market, potentially offering downside protection.

Competidores y Pares

Fortalezas

  • Strategic partnership with Walmart.
  • High gross margin and profit margin.
  • Established presence in Canada and Mexico.
  • Focus on convenient, accessible primary care.

Debilidades

  • Reliance on relationship with Walmart.
  • Limited geographic diversification.
  • Competition from other healthcare providers.
  • Potential regulatory changes.

Catalizadores

  • Ongoing: Expansion within existing and new Walmart locations in Canada and Mexico.
  • Upcoming: Potential partnerships with other retail chains to expand reach.
  • Upcoming: Introduction of new healthcare services, such as specialized medical care and diagnostic testing.
  • Ongoing: Leveraging telemedicine and virtual care technologies to improve access to healthcare services.
  • Upcoming: Strategic acquisitions of other healthcare providers or related businesses.

Riesgos

  • Ongoing: Reliance on relationship with Walmart could be a risk if the partnership changes.
  • Potential: Regulatory changes in the healthcare industry could impact operations and profitability.
  • Potential: Competition from other healthcare providers could erode market share.
  • Potential: Economic downturn could reduce consumer spending on healthcare services.
  • Ongoing: Limited liquidity due to OTC market trading could lead to difficulty in buying or selling shares.

Oportunidades de crecimiento

  • Expansion within Walmart locations: Jack Nathan Medical Corp. can expand its presence within existing and new Walmart locations in Canada and Mexico. The market size for retail-based healthcare clinics is estimated to reach $40 billion by 2027, driven by increasing consumer demand for convenient access to primary care services. The company's partnership with Walmart provides a significant competitive advantage, allowing it to leverage the retailer's high foot traffic and brand recognition. This expansion could be realized over the next 3-5 years.
  • Partnerships with other retail chains: Jack Nathan Medical Corp. can pursue partnerships with other retail chains to expand its reach beyond Walmart locations. The market for retail-based healthcare clinics is growing rapidly, with increasing demand from consumers for convenient access to primary care services. By partnering with other retail chains, the company can tap into new customer segments and expand its geographic footprint. This diversification strategy could be implemented over the next 2-4 years.
  • Expansion of service offerings: Jack Nathan Medical Corp. can expand its service offerings to include additional healthcare services, such as specialized medical care, diagnostic testing, and wellness programs. The market for specialized healthcare services is growing rapidly, driven by increasing demand from consumers for comprehensive healthcare solutions. By expanding its service offerings, the company can attract new patients and increase revenue per patient. This expansion could be implemented over the next 1-3 years.
  • Telemedicine and virtual care: Jack Nathan Medical Corp. can leverage telemedicine and virtual care technologies to expand its reach and improve access to healthcare services. The market for telemedicine and virtual care is growing rapidly, driven by increasing consumer demand for convenient and affordable healthcare solutions. By offering telemedicine and virtual care services, the company can reach patients who are unable to visit its physical clinics, as well as improve access to care for patients in remote areas. This technology integration could be implemented over the next 1-2 years.
  • Strategic acquisitions: Jack Nathan Medical Corp. can pursue strategic acquisitions of other healthcare providers or related businesses to expand its market share and service offerings. The healthcare industry is highly fragmented, with numerous small and medium-sized providers. By acquiring complementary businesses, the company can expand its geographic footprint, increase its service offerings, and gain access to new technologies and expertise. These acquisitions could be pursued over the next 3-5 years.

Oportunidades

  • Expansion within Walmart locations.
  • Partnerships with other retail chains.
  • Expansion of service offerings.
  • Telemedicine and virtual care.

Amenazas

  • Competition from other healthcare providers.
  • Regulatory changes.
  • Economic downturn.
  • Changes in consumer preferences.

Ventajas competitivas

  • Strategic partnership with Walmart provides exclusive access to high-traffic retail locations.
  • Established brand recognition and reputation for convenient healthcare access.
  • Integrated healthcare solutions offering a range of medical services.
  • Geographic presence in Canada and Mexico provides diversification.

Acerca de JNHMF

Founded in 2006 and headquartered in Woodbridge, Canada, Jack Nathan Medical Corp. operates primary care medical clinics under the Jack Nathan Health brand. The company's core strategy involves establishing clinics within Walmart Supercentres, providing convenient healthcare access to Walmart shoppers. As of June 30, 2022, Jack Nathan Medical operated 76 clinics in Walmart locations across Canada, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec. In addition to its Walmart-based clinics, the company also operates 4 clinics outside of Walmart locations. Expanding its service offerings, Jack Nathan Medical operates 18 medical clinics, 2 rehabilitation centers, and 5 MedSpa locations. The company has also expanded into Mexico, with 108 corporate-owned and operated clinics located within Walmart stores. This strategic positioning leverages the high foot traffic of Walmart stores to drive patient volume and brand awareness. The company's focus on integrated healthcare solutions and convenient access differentiates it from traditional healthcare providers.

Qué hacen

  • Operates primary care medical clinics within Walmart Supercentres.
  • Provides convenient healthcare access to Walmart shoppers.
  • Offers a range of medical services, including primary care, rehabilitation, and MedSpa treatments.
  • Operates clinics in Canada and Mexico.
  • Focuses on integrated healthcare solutions.
  • Leverages the high foot traffic of Walmart stores to drive patient volume.

Modelo de Negocio

  • Generates revenue from providing medical services to patients.
  • Partners with Walmart to establish clinics within Walmart Supercentres.
  • Operates corporate-owned and operated clinics in Mexico.
  • Focuses on convenient, accessible primary care.

Contexto de la Industria

Jack Nathan Medical Corp. operates within the growing market for accessible and convenient healthcare solutions. The trend towards retail-based healthcare clinics is driven by increasing consumer demand for convenient access to primary care services. The competitive landscape includes traditional healthcare providers, as well as other retail-based clinic operators. Jack Nathan Medical differentiates itself through its exclusive partnership with Walmart, leveraging the retailer's high foot traffic and brand recognition. The company's focus on integrated healthcare solutions and convenient access positions it to capitalize on the growing demand for accessible primary care services.

Clientes Clave

  • Walmart shoppers seeking convenient healthcare access.
  • Individuals and families in Canada and Mexico.
  • Patients seeking primary care, rehabilitation, and MedSpa treatments.
  • Consumers looking for integrated healthcare solutions.
Confianza de la IA: 71% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Jack Nathan Medical Corp. (JNHMF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para JNHMF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para JNHMF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para JNHMF.

MoonshotScore

45/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de JNHMF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Michael Di Cesare

CEO

Michael Di Cesare serves as the CEO of Jack Nathan Medical Corp. His background includes extensive experience in business development, strategic planning, and operations management within the healthcare sector. He has a proven track record of driving growth and profitability for healthcare organizations. Di Cesare's leadership is focused on expanding Jack Nathan Medical's presence in Canada and Mexico, as well as developing new partnerships and service offerings.

Historial: Under Michael Di Cesare's leadership, Jack Nathan Medical Corp. has expanded its footprint within Walmart locations in Canada and Mexico. He has overseen the development of new service offerings, including rehabilitation and MedSpa treatments. Di Cesare has also focused on improving operational efficiency and profitability, resulting in a high gross margin and profit margin for the company.

Información del mercado OTC de JNHMF

The OTC Other tier represents the lowest tier of the OTC market, indicating that Jack Nathan Medical Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and liquidity.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for stocks on the OTC Other tier, like JNHMF, is typically very limited. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volume can also lead to significant price volatility, increasing the risk of substantial losses. Investors should exercise extreme caution when trading JNHMF due to the potential for illiquidity and price manipulation.
Factores de riesgo OTC:
  • Limited liquidity and wide bid-ask spreads.
  • Lack of regulatory oversight and transparency.
  • Potential for price manipulation and fraud.
  • Limited financial information and disclosure.
  • Higher risk of delisting or going out of business.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and disclosures.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and legal risks.
  • Monitor trading volume and price volatility.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
Señales de legitimidad:
  • Operation of clinics within established Walmart locations.
  • Positive gross and profit margins.
  • CEO with experience in the healthcare sector.
  • Established presence in Canada and Mexico.

Lo Que los Inversores Preguntan Sobre Jack Nathan Medical Corp. (JNHMF)

¿Cuáles son los factores clave para evaluar JNHMF?

Jack Nathan Medical Corp. (JNHMF) actualmente tiene una puntuación IA de 45/100, indicando puntuación baja. Fortaleza clave: Strategic partnership with Walmart.. Riesgo principal a monitorear: Ongoing: Reliance on relationship with Walmart could be a risk if the partnership changes.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de JNHMF?

JNHMF actualmente puntúa 45/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de JNHMF?

Los precios de JNHMF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre JNHMF?

La cobertura de analistas para JNHMF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en JNHMF?

Las categorías de riesgo para JNHMF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Reliance on relationship with Walmart could be a risk if the partnership changes.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de JNHMF?

La relación P/E para JNHMF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está JNHMF sobrevalorada o infravalorada?

Determinar si Jack Nathan Medical Corp. (JNHMF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de JNHMF?

Jack Nathan Medical Corp. (JNHMF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data is based on information available as of 2022-06-30.
  • AI analysis is pending and may provide further insights.
Fuentes de datos

Popular Stocks